Zhang Lei, Bi Qingqing, Deng Hua, Xu Jing, Chen Juan, Zhang Meilian, Mu Xiaofeng
Department of Laboratory Medicine, Qingdao Central Hospital, Second Affiliated Hospital of Qingdao University, Siliunan Road #127, Qingdao, 266042, China.
Department of Pathology, Qingdao Central Hospital, Qingdao, China.
BMC Infect Dis. 2017 Jan 31;17(1):107. doi: 10.1186/s12879-017-2223-1.
Cervical cancer and its precursor, high-grade cervical intraepithelial neoplasia (CIN2/3), are associated with persistent high-risk human papillomavirus (HPV) infection. HPV genotype prevalence varies with severity of cervical lesions, patient age and geographical location. The aim of this study was to investigate HPV genotypes prevalence and attribution according to the severity of cervical lesions among Chinese women.
A 4-year surveillance study was performed. A total of 1664 female patients were included and their cervical histological diagnosis consisted of cervical intraepithelial neoplasia grade 1 (CIN1, 376 cases), grade 2 (CIN2, 408 cases), grade 3 (CIN3, 336 cases) and invasive cervical cancers (ICC, 544 cases). HPV genotypes prevalence and attribution to cervical lesions were calculated and analyzed. The 95% confidence interval (CI) for proportion was also calculated.
HPV positivity rates increased directly with cervical lesions severity (72.4% for CIN1, 81.4% for CIN2, 88.1% for CIN3 and 90.4% for ICC). Infections with multiple HPV types were inversely related to cervical lesions severity. HPV16, 52, 31, 33 and 58 were the most prevalent genotypes in ICC. 49.1% of squamous cell carcinoma, 65.1% of adenocarcinoma and 12.0-43.3% of cervical intraepithelial neoplasia could be attributed to vaccine-covered high-risk genotypes (HPV16/18). Inclusion of HPV52 and HPV31 in future vaccines would provide the highest marginal benefit in protection for individuals residing in this region.
These findings provide information about HPV genotypes in this region which may be important to target with future vaccination and screening programs.
宫颈癌及其癌前病变,即高级别宫颈上皮内瘤变(CIN2/3),与持续性高危型人乳头瘤病毒(HPV)感染相关。HPV基因型的流行率因宫颈病变的严重程度、患者年龄和地理位置而异。本研究的目的是调查中国女性中HPV基因型的流行率及其与宫颈病变严重程度的关系。
进行了一项为期4年的监测研究。共纳入1664例女性患者,其宫颈组织学诊断包括宫颈上皮内瘤变1级(CIN1,376例)、2级(CIN2,408例)、3级(CIN3,336例)和浸润性宫颈癌(ICC,544例)。计算并分析HPV基因型的流行率及其与宫颈病变的关系。还计算了比例的95%置信区间(CI)。
HPV阳性率随宫颈病变严重程度直接升高(CIN1为72.4%,CIN2为81.4%,CIN3为88.1%,ICC为90.4%)。多种HPV类型感染与宫颈病变严重程度呈负相关。HPV16、52、31、33和58是ICC中最常见的基因型。49.1%的鳞状细胞癌、65.1%的腺癌和12.0 - 43.3%的宫颈上皮内瘤变可归因于疫苗覆盖的高危基因型(HPV16/18)。未来疫苗中纳入HPV52和HPV31将为该地区居民提供最高的边际保护效益。
这些发现提供了该地区HPV基因型的信息,这可能对未来的疫苗接种和筛查计划具有重要意义。